Maldives vs Montserrat: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Maldives
0.2%
in 2024
Montserrat
0.2%
in 2024
Maldives rank
78th
Montserrat rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Maldives
- Montserrat
How they compare
Maldives currently reports 0.2% against 0.2% in Montserrat, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Maldives ahead.
Maldives ranks 78th and Montserrat ranks 78th of 215 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Maldives | Montserrat | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.3% | 0.1% | Maldives |
| 2020s | 0.2% | 0.2% | 0.0% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Maldives or Montserrat?
- Maldives, at 0.2% against 0.2% in Montserrat as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Maldives and Montserrat?
- 0.0%, with Maldives ahead.
- How many years of comparable data are there for Maldives and Montserrat?
- 10 years are reported by both, from 2015 to 2024.
- How do Maldives and Montserrat rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Maldives ranks 78th and Montserrat ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.